查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1551731

糖尿病眼科疾病設備的全球市場

Diabetic Eye Disease Devices
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 270 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球糖尿病眼科疾病設備市場將達到 16 億美元

全球糖尿病眼科疾病設備市場預計到 2023 年將達到 10 億美元，預計到 2030 年將達到 16 億美元，2023-2030 年分析期間複合年成長率為 6.2%。玻璃體手術是本報告分析的細分市場之一，預計複合年成長率為 6.4%，到分析期結束時將達到 12 億美元。在分析期間，雷射手術領域的複合年成長率預計為 5.7%。

美國市場預估為2.795億美元，中國預期複合年成長率為10.1%

預計2023年美國糖尿病眼科疾病設備市場規模將達2.795億美元。中國作為全球第二大經濟體，預計2030年市場規模將達3.375億美元，2023-2030年複合年成長率為10.1%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 2.6% 和 6.3%。在歐洲，德國的複合年成長率預計為 3.9%。

全球糖尿病眼科疾病設備市場－主要趨勢與促進因素總結

什麼是糖尿病眼科疾病設備？

糖尿病眼科疾病設備是一種專門的醫療工具和技術，旨在診斷、監測和治療與糖尿病相關的眼部疾病，如糖尿病視網膜病變、糖尿病黃斑部水腫、白內障和青光眼。如果不及時發現和治療，這些疾病可能導致嚴重的視力損害和失明。糖尿病眼科疾病設備在這些疾病的早期檢測和持續管理中發揮重要作用，鑑於糖尿病眼科疾病的進行性，這一點至關重要。鑑於糖尿病眼科疾病的進行性，糖尿病眼科疾病設備極為重要。這些設備的重要性在於它們能夠識別視網膜損傷的早期跡象，例如微動脈瘤和出血，而患者在視力顯著下降之前可能不會注意到這些跡象。透過及時干預，這些設備可以幫助預防或減緩糖尿病眼科疾病的進展，從而保護視力並改善患者的生活品質。隨著全球糖尿病盛行率持續上升，在對抗糖尿病相關視力喪失方面，對有效、可靠的糖尿病眼科疾病設備的需求比以往任何時候都更加重要。

科技進步如何增強糖尿病眼科疾病設備？

技術進步顯著提高了糖尿病眼科疾病設備的有效性、準確性和可近性。光同調斷層掃瞄(OCT) 和眼底攝影等現代診斷工具可提供高解析度的視網膜影像，從而可以詳細檢查眼睛的內部結構。這些技術使臨床醫生能夠識別出顯示疾病進展的視網膜細微變化，從而徹底改變了糖尿病視網膜病變和黃斑部水腫的早期檢測。此外，將人工智慧（AI）和機器學習演算法整合到這些設備中進一步提高了診斷準確性和效率。人工智慧驅動的視網膜篩檢工具可以高精度地分析影像，尋找糖尿病眼科疾病的徵兆，通常可以匹配甚至超過人類專家的表現。這項技術在眼科醫生有限的偏遠和服務欠缺地區尤其有價值。此外，雷射治療設備的進步，例如用於全視網膜光凝固和聚焦雷射治療的設備，正在提高治療性介入的準確性和安全性，降低併發症的風險，並改善患者的治療效果。這些技術改進不僅使糖尿病眼科疾病設備更有效，而且提高了其可用性和易用性，使更多患者得到及時、適當的治療。

為什麼患者和醫療保健提供者接受糖尿病眼科疾病設備？

由於迫切需要管理日益增加的糖尿病相關眼科疾病負擔，患者和醫療保健提供者擴大採用糖尿病眼科疾病設備。對於患者來說，這些設備提供了一種積極主動的眼睛健康方法，可以定期監測並及早發現潛在問題，避免導致視力嚴重喪失。此外，視網膜成像和 OCT 掃描等非侵入性診斷測試的便利性使患者更容易接受定期檢查，而不會感到不適或冗長的程序。此外，隨著人們對糖尿病眼科疾病相關風險的認知不斷提高，以及先進篩檢技術的出現，越來越多的患者接受定期眼科檢查，作為糖尿病管理計畫的一部分。對於醫療保健提供者而言，糖尿病眼科疾病設備提供了一種可靠且有效的方法來診斷糖尿病患者的眼睛狀況並追蹤其進展。儘早檢測視網膜的細微變化的能力可以及時進行干預，以防止嚴重併發症並最終改善患者的治療結果。此外，將人工智慧和遠端醫療解決方案整合到這些設備中將擴大獲得專業護理的機會，特別是在眼科服務較差的地區，使這些設備成為現代糖尿病管理的重要工具。

推動糖尿病眼科疾病設備市場成長的因素有哪些？

糖尿病眼科疾病設備市場的成長是由幾個關鍵因素推動的，這些因素反映了全球糖尿病盛行率的不斷上升以及併發症進行有效管理的需要。主要因素之一是全世界糖尿病盛行率不斷上升，特別是在高齡化社會以及肥胖率和久坐生活方式高的地區。隨著越來越多的人被診斷出患有糖尿病，對能夠監測和治療相關眼部疾病的設備的需求正在迅速增加。高解析度成像系統的開發、人工智慧診斷工具和更精確的雷射治療等技術進步也在市場擴張中發揮關鍵作用。這些創新提高了糖尿病眼部護理的準確性、安全性和可近性，從而實現更早、更有效的診斷和治療。此外，對預防性醫療保健和早期檢測的重視、對篩檢項目的投資增加以及在常規醫療護理中採用糖尿病眼科疾病設備也是推動市場成長的主要因素。此外，新興市場不斷擴大的醫療基礎設施以及政府為對抗糖尿病導致的失明所做的努力進一步推動了對這些設備的需求。最後，提高患者對定期眼科檢查重要性的認知以及先進診斷選擇的可用性正在促進市場的持續擴張，糖尿病眼科疾病設備可能會繼續治療糖尿病。

受訪企業範例（共36家）

  • Aaren Scientific Inc.
  • Alcon Inc.
  • Bausch+Lomb
  • Carl Zeiss Meditec AG
  • CooperVision, Inc.
  • Essilor International SA
  • IRIDEX Corporation
  • Johnson & Johnson Innovative Medicine
  • Lumenis Be Ltd.
  • Nidek Co., Ltd.
  • Novartis AG
  • STAAR Surgical Company
  • Stryker Corporation;

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 比賽

簡介目錄
Product Code: MCP26707

Global Diabetic Eye Disease Devices Market to Reach US$1.6 Billion by 2030

The global market for Diabetic Eye Disease Devices estimated at US$1.0 Billion in the year 2023, is expected to reach US$1.6 Billion by 2030, growing at a CAGR of 6.2% over the analysis period 2023-2030. Vitrectomy, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$1.2 Billion by the end of the analysis period. Growth in the Laser Surgery segment is estimated at 5.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$279.5 Million While China is Forecast to Grow at 10.1% CAGR

The Diabetic Eye Disease Devices market in the U.S. is estimated at US$279.5 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$337.5 Million by the year 2030 trailing a CAGR of 10.1% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.6% and 6.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.

Global Diabetic Eye Disease Devices Market - Key Trends and Drivers Summarized

What Are Diabetic Eye Disease Devices and Why Are They Essential?

Diabetic eye disease devices are specialized medical tools and technologies designed to diagnose, monitor, and treat eye conditions associated with diabetes, such as diabetic retinopathy, diabetic macular edema, cataracts, and glaucoma. These conditions can lead to severe vision impairment or even blindness if not detected and managed promptly. Diabetic eye disease devices play a crucial role in the early detection and ongoing management of these conditions, which is vital given the progressive nature of diabetic eye diseases. The importance of these devices lies in their ability to identify early signs of retinal damage, such as microaneurysms or hemorrhages, that might not be noticeable to the patient until significant vision loss has occurred. By enabling timely interventions, these devices help prevent or slow the progression of diabetic eye diseases, thereby preserving vision and improving the quality of life for patients. As the global prevalence of diabetes continues to rise, the demand for effective and reliable diabetic eye disease devices has become more critical than ever in the fight against diabetes-related blindness.

How Are Technological Advances Enhancing Diabetic Eye Disease Devices?

Technological advancements have significantly enhanced the effectiveness, accuracy, and accessibility of diabetic eye disease devices. Modern diagnostic tools, such as optical coherence tomography (OCT) and fundus photography, provide high-resolution images of the retina, allowing for detailed examination of the eye's internal structures. These technologies have revolutionized the early detection of diabetic retinopathy and macular edema by enabling clinicians to identify minute changes in the retina that might indicate disease progression. Additionally, the integration of artificial intelligence (AI) and machine learning algorithms into these devices has further improved diagnostic accuracy and efficiency. AI-powered retinal screening tools can analyze images for signs of diabetic eye disease with a high degree of accuracy, often matching or even surpassing the performance of human experts. This technology is particularly valuable in remote or underserved areas, where access to ophthalmologists may be limited. Moreover, advancements in laser therapy devices, such as those used in panretinal photocoagulation or focal laser treatments, have improved the precision and safety of therapeutic interventions, reducing the risk of complications and enhancing patient outcomes. These technological improvements not only make diabetic eye disease devices more effective but also increase their availability and usability, helping more patients receive timely and appropriate care.

Why Are Patients and Healthcare Providers Embracing Diabetic Eye Disease Devices?

The growing adoption of diabetic eye disease devices by both patients and healthcare providers is driven by the pressing need to manage the rising burden of diabetes-related eye conditions. For patients, these devices offer a proactive approach to eye health, enabling regular monitoring and early detection of potential issues before they lead to significant vision loss. The convenience of non-invasive diagnostic tests, such as retinal imaging and OCT scans, also makes it easier for patients to undergo regular check-ups without discomfort or lengthy procedures. Additionally, the increasing awareness of the risks associated with diabetic eye disease, combined with the availability of advanced screening technologies, has encouraged more patients to seek regular eye care as part of their diabetes management plan. For healthcare providers, diabetic eye disease devices provide a reliable and efficient means of diagnosing and tracking the progression of eye conditions in diabetic patients. The ability to detect subtle retinal changes early on allows for timely interventions that can prevent severe complications, ultimately improving patient outcomes. Furthermore, the integration of AI and telemedicine solutions into these devices has expanded access to specialized care, particularly in regions where ophthalmology services are scarce, making these devices an indispensable tool in modern diabetes management.

What Factors Are Driving the Growth of the Diabetic Eye Disease Devices Market?

The growth in the diabetic eye disease devices market is driven by several key factors that reflect the increasing global prevalence of diabetes and the need for effective management of its complications. One of the primary drivers is the rising incidence of diabetes worldwide, particularly in aging populations and regions with high rates of obesity and sedentary lifestyles. As more people are diagnosed with diabetes, the demand for devices that can monitor and treat associated eye conditions has surged. Technological advancements, including the development of high-resolution imaging systems, AI-powered diagnostic tools, and more precise laser therapies, have also played a crucial role in expanding the market. These innovations have improved the accuracy, safety, and accessibility of diabetic eye care, making it possible to diagnose and treat conditions earlier and more effectively. Another significant factor driving market growth is the increasing emphasis on preventive healthcare and early detection, which has led to greater investment in screening programs and the adoption of diabetic eye disease devices in routine clinical practice. Additionally, the expansion of healthcare infrastructure in emerging markets, along with government initiatives to combat diabetes-related blindness, has further fueled the demand for these devices. Lastly, the growing awareness among patients about the importance of regular eye exams and the availability of advanced diagnostic options has contributed to the market's continued expansion, ensuring that diabetic eye disease devices will remain a critical component of diabetes care in the years to come.

Select Competitors (Total 36 Featured) -

  • Aaren Scientific Inc.
  • Alcon Inc.
  • Bausch + Lomb
  • Carl Zeiss Meditec AG
  • CooperVision, Inc.
  • Essilor International S.A.
  • IRIDEX Corporation
  • Johnson & Johnson Innovative Medicine
  • Lumenis Be Ltd.
  • Nidek Co., Ltd.
  • Novartis AG
  • STAAR Surgical Company
  • Stryker Corporation;

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Diabetic Eye Disease Devices - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Diabetes Expands Addressable Market Opportunity for Diabetic Eye Care
    • Advancements in Diagnostic Imaging Propel Growth in Diabetic Eye Disease Devices
    • Integration of AI and Machine Learning Strengthens the Business Case for Early Detection and Monitoring
    • Growing Focus on Preventive Healthcare Drives Adoption of Early Detection and Monitoring Tools
    • Innovations in Non-Invasive Testing Spur Growth in Diabetic Eye Disease Management
    • Increasing Awareness of Diabetic Retinopathy and Other Complications Generates Demand for Screening Devices
    • Expanding Healthcare Access Create New Growth Avenues for Diabetic Eye Disease Devices
    • Focus on Patient Compliance and User-Friendly Designs Sustains Growth in Home Monitoring Solutions
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Diabetic Eye Disease Devices Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Diabetic Eye Disease Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Diabetic Eye Disease Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Vitrectomy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Vitrectomy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Vitrectomy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Laser Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Laser Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Laser Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Ophthalmic Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Ophthalmic Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Ophthalmic Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Diabetic Eye Disease Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • JAPAN
    • Diabetic Eye Disease Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • CHINA
    • Diabetic Eye Disease Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: China 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • EUROPE
    • Diabetic Eye Disease Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Diabetic Eye Disease Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for Diabetic Eye Disease Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • FRANCE
    • Diabetic Eye Disease Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: France 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • GERMANY
    • Diabetic Eye Disease Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Germany 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Italy 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Diabetic Eye Disease Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: UK 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Spain 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Russia 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Rest of Europe 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Diabetic Eye Disease Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Diabetic Eye Disease Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Asia-Pacific 16-Year Perspective for Diabetic Eye Disease Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Diabetic Eye Disease Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Australia 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • INDIA
    • Diabetic Eye Disease Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 110: India Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: India 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 113: India Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: India 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: South Korea 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Diabetic Eye Disease Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Diabetic Eye Disease Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: Latin America 16-Year Perspective for Diabetic Eye Disease Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Argentina 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Brazil 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 151: Mexico 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 157: Rest of Latin America 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Diabetic Eye Disease Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Diabetic Eye Disease Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 163: Middle East 16-Year Perspective for Diabetic Eye Disease Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 172: Iran 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 178: Israel 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 184: Saudi Arabia 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 190: UAE 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 196: Rest of Middle East 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • AFRICA
    • Diabetic Eye Disease Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 202: Africa 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION